Hours worked
17500 +
Protocols involved
20 +
Sponsors secured
10 +
Департамент клинических исследований
Департамент клинических исследований
Clinical trials department
Why pharmaceutical companies choose us?
Our approach
Four simple steps for a successful clinical trial startClinical trial feasibility study
Ethics assessment
Patient enrollment channels evaluation
Step-by-step trial planning
Our resources
We are all set for conducting top notch clinical trials
"Big Pharma" trust us
If you are interested in a reliable partner for conducting top notch phase II-III clinical trials on a wide range of nosologies and still do not work with us, please contact us
News
Stay up to date
Completion of the study
A clinical trial under the UKM-PS-III protocol has been completed. Thanks to all the participants!
Evaluation of the possibility of conducting clinical trials of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population.
Participation in a clinical trial of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population is being considered.
The visit of the selection center to participate in two studies of biological drugs for the treatment of IBD has been successfully completed.
A new drug for the treatment of IBD will be tested at our center. The study will begin in July 2025, we invite patients for pre-selection!
Our partners
